National Institute of Allergy and Infectious Diseases; Notice of Meetings, 92947-92948 [2024-27485]

Download as PDF Federal Register / Vol. 89, No. 227 / Monday, November 25, 2024 / Notices khammond on DSK9W7S144PROD with NOTICES amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Epidemiology, Prevention and Behavior Research Study Section. Date: February 25, 2025. Time: 10:00 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Address: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Anna Ghambaryan, M.D., Ph.D., Scientific Review Officer, Extramural Project Review Branch, Office of Extramural Activities, 6700B Rockledge Drive, Room 2120, MSC 6902, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, Tel: 301–443–4032, Email: anna.ghambaryan@nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Neuroscience and Behavior Study Section. Date: March 4, 2025. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Beata Buzas, Ph.D., Scientific Review Officer, Extramural Project Review Branch, Office of Extramural Activities, 6700B Rockledge Drive, Room 2116, MSC 6902, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, Tel: 301–443–0800, Email: bbuzas@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.273, Alcohol Research Programs, National Institutes of Health, HHS) Dated: November 19, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–27534 Filed 11–22–24; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:29 Nov 22, 2024 Jkt 265001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council. The meetings will be held as virtual meetings and will be open to the public as indicated below. Individuals who plan to view the virtual meetings and need special assistance or other reasonable accommodations to view the meetings should notify the Contact Person listed below in advance of the meetings. The meetings can be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Allergy and Infectious Diseases Council. Date: January 27, 2025. Open: 10:30 a.m. to 11:30 a.m. Agenda: Report of Institute Director. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Video Assisted Meeting). Closed: 11:45 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Video Assisted Meeting). Contact Person: Kelly Y. Poe, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, poeky@mail.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council Allergy, Immunology and Transplantation Subcommittee. Date: January 27, 2025. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 92947 Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Video Assisted Meeting). Open: 1:00 p.m. to 4:00 p.m. Agenda: Report of the Division Director and Division Staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Video Assisted Meeting). Contact Person: Kelly Y. Poe, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, poeky@mail.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council Microbiology and Infectious Diseases Subcommittee. Date: January 27, 2025. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Video Assisted Meeting). Open: 1:00 p.m. to 4:00 p.m. Agenda: Report of the Division Director and Division Staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Video Assisted Meeting). Contact Person: Kelly Y. Poe, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, poeky@mail.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council Acquired Immunodeficiency Syndrome Subcommittee. Date: January 27, 2025. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Video Assisted Meeting). Open: 1:00 p.m. to 4:00 p.m. Agenda: Report of Division Director and Division Staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Video Assisted Meeting). Contact Person: Kelly Y. Poe, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious, Diseases National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, poeky@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice at least 10 days in advance of the meeting. The statement should include the E:\FR\FM\25NON1.SGM 25NON1 92948 Federal Register / Vol. 89, No. 227 / Monday, November 25, 2024 / Notices name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.niaid.nih.gov/about/advisory-council, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 19, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. of Health, 6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, 301–402–6711, cheryl.nordstrom@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: November 19, 2024 Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–27536 Filed 11–22–24; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2024–27485 Filed 11–22–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Emergency Management Agency National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. khammond on DSK9W7S144PROD with NOTICES Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK RC2 Application Review. Date: February 13, 2025. Time: 12:00 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Cheryl Nordstrom, Ph.D., MPH, Scientific Review Officer, NIDDK/ Scientific Review Branch, National Institutes Final Flood Hazard Determinations Federal Emergency Management Agency, Department of Homeland Security. ACTION: Notice. AGENCY: Flood hazard determinations, which may include additions or modifications of Base Flood Elevations (BFEs), base flood depths, Special Flood Hazard Area (SFHA) boundaries or zone designations, or regulatory floodways on the Flood Insurance Rate Maps (FIRMs) and where applicable, in the supporting Flood Insurance Study (FIS) reports have been made final for the communities listed in the table below. The FIRM and FIS report are the basis of the floodplain management measures that a community is required either to adopt or to show evidence of having in effect in order to qualify or remain qualified for participation in the Federal Emergency Management Agency’s (FEMA’s) National Flood Insurance Program (NFIP). DATES: The date of February 28, 2025 has been established for the FIRM and, where applicable, the supporting FIS report showing the new or modified flood hazard information for each community. ADDRESSES: The FIRM, and if applicable, the FIS report containing the SUMMARY: Community Rick Sacbibit, Chief, Engineering Services Branch, Federal Insurance and Mitigation Administration, FEMA, 400 C Street SW, Washington, DC 20472, (202) 646–7659, or (email) patrick.sacbibit@fema.dhs.gov; or visit the FEMA Mapping and Insurance eXchange (FMIX) online at https:// www.floodmaps.fema.gov/fhm/fmx_ main.html. FOR FURTHER INFORMATION CONTACT: The Federal Emergency Management Agency (FEMA) makes the final determinations listed below for the new or modified flood hazard information for each community listed. Notification of these changes has been published in newspapers of local circulation and 90 days have elapsed since that publication. The Deputy Associate Administrator for Insurance and Mitigation has resolved any appeals resulting from this notification. This final notice is issued in accordance with section 110 of the Flood Disaster Protection Act of 1973, 42 U.S.C. 4104, and 44 CFR part 67. FEMA has developed criteria for floodplain management in floodprone areas in accordance with 44 CFR part 60. Interested lessees and owners of real property are encouraged to review the new or revised FIRM and FIS report available at the address cited below for each community or online through the FEMA Map Service Center at https:// msc.fema.gov. The flood hazard determinations are made final in the watersheds and/or communities listed in the table below. SUPPLEMENTARY INFORMATION: [Docket ID FEMA–2024–0002] National Institutes of Health final flood hazard information for each community is available for inspection at the respective Community Map Repository address listed in the tables below and will be available online through the FEMA Map Service Center at https://msc.fema.gov by the date indicated above. (Catalog of Federal Domestic Assistance No. 97.022, ‘‘Flood Insurance.’’) Nicholas A. Shufro, Assistant Administrator (Acting) for Risk Management, Federal Emergency Management Agency, Department of Homeland Security. Community map repository address Kenai Peninsula Borough, Alaska and Incorporated Areas Docket No.: FEMA–B–2351 City of Kenai ............................................................................................. City of Soldotna ........................................................................................ VerDate Sep<11>2014 18:29 Nov 22, 2024 Jkt 265001 PO 00000 Frm 00065 Fmt 4703 City Hall, 210 Fidalgo Avenue, Kenai, AK 99611. City Hall, 177 North Birch Street, Soldotna, AK 99669. Sfmt 4703 E:\FR\FM\25NON1.SGM 25NON1

Agencies

[Federal Register Volume 89, Number 227 (Monday, November 25, 2024)]
[Notices]
[Pages 92947-92948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-27485]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the National Advisory 
Allergy and Infectious Diseases Council.
    The meetings will be held as virtual meetings and will be open to 
the public as indicated below. Individuals who plan to view the virtual 
meetings and need special assistance or other reasonable accommodations 
to view the meetings should notify the Contact Person listed below in 
advance of the meetings. The meetings can be accessed from the NIH 
Videocast at the following link: https://videocast.nih.gov/.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council.
    Date: January 27, 2025.
    Open: 10:30 a.m. to 11:30 a.m.
    Agenda: Report of Institute Director.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Closed: 11:45 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Allergy, Immunology and Transplantation 
Subcommittee.
    Date: January 27, 2025.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of the Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Microbiology and Infectious Diseases Subcommittee.
    Date: January 27, 2025.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of the Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Acquired Immunodeficiency Syndrome Subcommittee.
    Date: January 27, 2025.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: Kelly Y. Poe, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious, 
Diseases National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice at least 10 days in advance of the meeting. The 
statement should include the

[[Page 92948]]

name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.niaid.nih.gov/about/advisory-council, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 19, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-27485 Filed 11-22-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.